Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma.
Satragno C, Schiavetti I, Cella E, Picichè F, Falcitano L, Resaz M, Truffelli M, Caneva S, Mattioli P, Esposito D, Ginulla A, Scaffidi C, Fiaschi P, D'Andrea A, Bianconi A, Zona G, Barletta L, Roccatagliata L, Castellan L, Morbelli S, Bauckneht M, Donegani I, Nozza P, Arnaldi D, Vidano G, Gianelli F, Barra S, Bennicelli E, Belgioia L; disease management team on Neuroncology of IRCCS Ospedale Policlinico San Martino. Satragno C, et al. Among authors: bennicelli e. Clin Transl Radiat Oncol. 2024 Aug 30;49:100849. doi: 10.1016/j.ctro.2024.100849. eCollection 2024 Nov. Clin Transl Radiat Oncol. 2024. PMID: 39318678 Free PMC article.
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients.
Parisi F, De Luca G, Mosconi M, Lastraioli S, Dellepiane C, Rossi G, Puglisi S, Bennicelli E, Barletta G, Zullo L, Santamaria S, Mora M, Ballestrero A, Montecucco F, Bellodi A, Del Mastro L, Lambertini M, Barisione E, Cittadini G, Tagliabue E, Spagnolo F, Tagliamento M, Coco S, Dono M, Genova C. Parisi F, et al. Among authors: bennicelli e. Cancer Treat Res Commun. 2024;41:100839. doi: 10.1016/j.ctarc.2024.100839. Epub 2024 Aug 23. Cancer Treat Res Commun. 2024. PMID: 39217684 Free article.
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.
Caccese M, Desideri I, Villani V, Simonelli M, Buglione M, Chiesa S, Franceschi E, Gaviani P, Stasi I, Caserta C, Brugnara S, Lolli I, Bennicelli E, Bini P, Cuccu AS, Scoccianti S, Padovan M, Gori S, Bonetti A, Giordano P, Pellerino A, Gregucci F, Riva N, Cinieri S, Internò V, Santoni M, Pernice G, Dealis C, Stievano L, Paiar F, Magni G, De Salvo GL, Zagonel V, Lombardi G. Caccese M, et al. Among authors: bennicelli e. ESMO Open. 2024 Apr;9(4):102943. doi: 10.1016/j.esmoop.2024.102943. Epub 2024 Mar 15. ESMO Open. 2024. PMID: 38492275 Free PMC article.
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
Ramoni D, Coco S, Rossi G, Dellepiane C, Bennicelli E, Santamaria S, Zinoli L, Tagliafico AS, Tagliamento M, Barletta G, Liberale L, Tirandi A, Minetti S, Bertolotto M, Montecucco F, Genova C, Carbone F. Ramoni D, et al. Among authors: bennicelli e. Lung. 2024 Apr;202(2):197-210. doi: 10.1007/s00408-024-00675-5. Epub 2024 Mar 13. Lung. 2024. PMID: 38480620 Free PMC article.
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center.
Vallome G, Cafaro I, Bottini A, Dellepiane C, Rossi G, Bennicelli E, Parisi F, Zullo L, Tagliamento M, Ballestrero A, Barisione E, Piroddi IMG, Montecucco F, Carbone F, Pronzato P, Lambertini M, Spagnolo F, Barletta G, Barcellini L, Ferrante M, Nardin S, Coco S, Marconi S, Zinoli L, Moscatelli P, Arboscello E, Del Mastro L, Bellodi A, Genova C. Vallome G, et al. Among authors: bennicelli e. Heliyon. 2023 Oct 19;9(11):e21177. doi: 10.1016/j.heliyon.2023.e21177. eCollection 2023 Nov. Heliyon. 2023. PMID: 37928020 Free PMC article.
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives.
Cella E, Zullo L, Marconi S, Rossi G, Coco S, Dellepiane C, Alama A, Rozeboom L, Bennicelli E, Parisi F, Sacco G, Barletta G, Zinoli L, Tagliamento M, Pronzato P, Genova C. Cella E, et al. Among authors: bennicelli e. Expert Opin Biol Ther. 2022 Oct;22(10):1259-1273. doi: 10.1080/14712598.2022.2116273. Epub 2022 Aug 28. Expert Opin Biol Ther. 2022. PMID: 35994596 Review.
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
Marconi S, Croce M, Chiorino G, Rossi G, Guana F, Profumo A, Ostano P, Alama A, Longo L, De Luca G, Dono M, Dal Bello MG, Ponassi M, Rosano C, Romano P, Cavalieri Z, Grassi M, Tagliamento M, Zullo L, Venturi C, Dellepiane C, Mastracci L, Bennicelli E, Pronzato P, Genova C, Coco S. Marconi S, et al. Among authors: bennicelli e. Cancers (Basel). 2022 Jul 14;14(14):3412. doi: 10.3390/cancers14143412. Cancers (Basel). 2022. PMID: 35884472 Free PMC article.
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, Kerr K, Wang C, Ciuleanu TE, Saylors GB, Tanaka F, Ito H, Chen KN, Liberman M, Vokes EE, Taube JM, Dorange C, Cai J, Fiore J, Jarkowski A, Balli D, Sausen M, Pandya D, Calvet CY, Girard N; CheckMate 816 Investigators. Forde PM, et al. N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11. N Engl J Med. 2022. PMID: 35403841 Free PMC article. Clinical Trial.
15 results